{
  "timestamp": "2026-01-20T01:36:57.375068",
  "method": "llm",
  "judge_model": "claude-3-haiku-20240307",
  "source_file": "/Users/shloknatarajan/stanford/research/daneshjou/autogkb-benchmark/src/experiments/sentence_generation/batch_judge_ask/outputs/gpt-5_v5_20260120_013649.json",
  "overall_avg_score": 0.8,
  "num_pmcids": 1,
  "per_pmcid": [
    {
      "pmcid": "PMC5508045",
      "avg_score": 0.8,
      "num_variants": 4,
      "per_variant": [
        {
          "variant": "rs9923231",
          "ground_truth": [
            "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC."
          ],
          "generated": [
            "Genotypes GA + AA of rs9923231 are associated with decreased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype GG.\nEXPLANATION: In a cohort of 250 Thai patients on stable warfarin therapy, multivariate modeling identified VKORC1 \u22121639G>A as a major predictor of dose, explaining 26.2% of variability (22.5% from AA and 3.7% from GA), indicating a significant association with lower dosing needs."
          ],
          "score": 0.8,
          "best_similarity": 0.2916666666666667,
          "best_gt": "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC.",
          "best_gen": "Genotypes GA + AA of rs9923231 are associated with decreased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype GG.\nEXPLANATION: In a cohort of 250 Thai patients on stable warfarin therapy, multivariate modeling identified VKORC1 \u22121639G>A as a major predictor of dose, explaining 26.2% of variability (22.5% from AA and 3.7% from GA), indicating a significant association with lower dosing needs.",
          "critique": "The generated sentence captures most of the key associations from the ground truth, with some minor differences in specificity and wording. The variant and genotypes mentioned are similar (rs9923231 GA+AA vs. CT+TT), the direction of association is the same (decreased dose), the effect type is the same (dose), and the drug mentioned is the same (warfarin). The phenotypes/conditions are also largely similar, with some additional conditions mentioned in the generated sentence (Deep Vein Thrombosis, Chronic Thromboembolic Pulmonary Hypertension). The comparison groups are also similar (GG vs. CC). Overall, the generated sentence captures the key pharmacogenomic associations, with some minor differences in specificity."
        },
        {
          "variant": "rs1057910",
          "ground_truth": [
            "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA."
          ],
          "generated": [
            "Genotypes AC + CC of rs1057910 are associated with decreased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype AA.\nEXPLANATION: The same study found CYP2C9 rs1057910 (*3; 1075A>C) to be a significant determinant, collectively explaining about 6.0% of dose variability (2.7% from heterozygous and 3.3% from homozygous variant genotypes) in multivariate regression."
          ],
          "score": 0.8,
          "best_similarity": 0.38461538461538464,
          "best_gt": "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA.",
          "best_gen": "Genotypes AC + CC of rs1057910 are associated with decreased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype AA.\nEXPLANATION: The same study found CYP2C9 rs1057910 (*3; 1075A>C) to be a significant determinant, collectively explaining about 6.0% of dose variability (2.7% from heterozygous and 3.3% from homozygous variant genotypes) in multivariate regression.",
          "critique": "The generated sentence captures most of the key associations from the ground truth, with some minor differences in specificity and wording. The variant, genotypes, direction of association (decreased dose), drug (warfarin), and some of the phenotypes/conditions (Atrial Fibrillation, Heart Valve Replacement, Pulmonary Embolism) are correctly mentioned. The generated sentence also provides additional context on the effect size. The only differences are that the generated sentence is more specific to the Thai population and includes some additional phenotypes (Deep Vein Thrombosis, Chronic Thromboembolic Pulmonary Hypertension) that are not explicitly mentioned in the ground truth. Overall, the key pharmacogenomic associations are well captured."
        },
        {
          "variant": "rs2108622",
          "ground_truth": [
            "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC."
          ],
          "generated": [
            "Genotype TT of rs2108622 is associated with increased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype CC.\nEXPLANATION: In multivariate analysis of the 250-patient Thai cohort, CYP4F2 rs2108622 was a significant, modest predictor of dosing, with the TT genotype accounting for about 1.2% of the variance in stable warfarin dose."
          ],
          "score": 0.8,
          "best_similarity": 0.375,
          "best_gt": "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",
          "best_gen": "Genotype TT of rs2108622 is associated with increased dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype CC.\nEXPLANATION: In multivariate analysis of the 250-patient Thai cohort, CYP4F2 rs2108622 was a significant, modest predictor of dosing, with the TT genotype accounting for about 1.2% of the variance in stable warfarin dose.",
          "critique": "The generated sentence captures the key associations from the ground truth, including the variant (rs2108622), the direction of association (increased dose), the effect type (dose), the drug (warfarin), and the comparison groups (TT vs CC genotype). The generated sentence also includes some additional phenotypes/conditions that were not explicitly mentioned in the ground truth, but these appear to be related and consistent with the overall association. The only minor difference is the specific population mentioned (Thai vs not specified). Overall, the generated sentence captures the core pharmacogenomic association very well."
        },
        {
          "variant": "rs887829",
          "ground_truth": [
            "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T."
          ],
          "generated": [
            "Genotypes CT + TT of rs887829 are not associated with dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype CC.\nEXPLANATION: The study of 250 Thai patients reported that UGT1A1 rs887829 showed no significant contribution to stable warfarin dose variability in univariate or multivariate analyses."
          ],
          "score": 0.8,
          "best_similarity": 0.2786885245901639,
          "best_gt": "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T.",
          "best_gen": "Genotypes CT + TT of rs887829 are not associated with dose of warfarin in Thai people with Atrial Fibrillation, Heart Valve Replacement, Deep Vein Thrombosis, Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension as compared to genotype CC.\nEXPLANATION: The study of 250 Thai patients reported that UGT1A1 rs887829 showed no significant contribution to stable warfarin dose variability in univariate or multivariate analyses.",
          "critique": "The generated sentence captures most of the key associations from the ground truth, with some minor differences in specificity. The variant and genotypes mentioned are the same, the direction of association (no association) is the same, and the effect type (dose) and drug (warfarin) are the same. The phenotypes/conditions are mostly the same, with some additional conditions mentioned in the generated sentence. The comparison groups are also the same. Overall, the generated sentence captures the key pharmacogenomic associations, with only minor differences in the specific conditions mentioned."
        }
      ],
      "generated_extras": []
    }
  ]
}